---
nav_exclude: true
layout: default
title: "Use of Additional Doses of 2024-2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=755545"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2024-12-12
seo:
  json_ld: |
    {
      "@context": "https://schema.org",
      "@graph": [
        {
          "@type": "WebPage",
          "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc#webpage",
          "url": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc",
          "name": "Use of Additional Doses of 2024-2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024",
          "description": "CDC MMWR 監測摘要：Use of Additional Doses of 2024-2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024",
          "inLanguage": "zh-TW",
          "datePublished": "2024-12-12",
          "dateModified": "2026-02-16",
          "isPartOf": {"@id": "https://epialert.weiqi.kids#website"},
          "primaryImageOfPage": {"@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc#primaryimage"},
          "breadcrumb": {"@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc#breadcrumb"},
          "speakable": {
            "@type": "SpeakableSpecification",
            "cssSelector": [".article-summary", ".speakable-content", ".key-takeaway", ".key-answer", ".expert-quote", ".actionable-steps li", ".faq-answer-content"]
          }
        },
        {
          "@type": "Article",
          "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc#article",
          "headline": "Use of Additional Doses of 2024-2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024",
          "description": "CDC MMWR 監測摘要：Use of Additional Doses of 2024-2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024",
          "datePublished": "2024-12-12",
          "dateModified": "2026-02-16",
          "author": {"@id": "https://epialert.weiqi.kids/about#person"},
          "publisher": {"@id": "https://epialert.weiqi.kids#organization"},
          "isPartOf": {"@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc#webpage"},
          "mainEntityOfPage": {"@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc#webpage"}
        },
        {
          "@type": "Person",
          "@id": "https://epialert.weiqi.kids/about#person",
          "name": "EpiAlert AI 編輯",
          "url": "https://epialert.weiqi.kids/about"
        },
        {
          "@type": "Organization",
          "@id": "https://epialert.weiqi.kids#organization",
          "name": "EpiAlert 疫情快訊",
          "url": "https://epialert.weiqi.kids",
          "logo": {
            "@type": "ImageObject",
            "url": "https://epialert.weiqi.kids/assets/images/logo.png"
          }
        },
        {
          "@type": "BreadcrumbList",
          "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc#breadcrumb",
          "itemListElement": [
            {"@type": "ListItem", "position": 1, "name": "首頁", "item": "https://epialert.weiqi.kids/"},
            {"@type": "ListItem", "position": 2, "name": "資料萃取", "item": "https://epialert.weiqi.kids/Extractor/"},
            {"@type": "ListItem", "position": 3, "name": "CDC MMWR", "item": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/"},
            {"@type": "ListItem", "position": 4, "name": "監測摘要", "item": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/"},
            {"@type": "ListItem", "position": 5, "name": "Use of Additional Doses of 2024-2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024", "item": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-use-of-additional-doses-of-2024-2025-covid-19-vacc"}
          ]
        }
      ]
    }
  ymyl: |
    **醫療健康資訊免責聲明**：本內容由 AI 自動萃取自 CDC MMWR 公開資料，僅供參考。如需專業醫療建議，請諮詢合格醫療人員。EpiAlert 不對內容準確性承擔責任。

confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes CDC's recommendation that all people aged ≥65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.

## 詳細內容

This report describes CDC's recommendation that all people aged ≥65 years and people ages 6 months-64 years with moderate or severe immunocompromise receive a second 2024-2025 COVID-19 vaccine dose 6 months after their last dose.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:09:23Z*
*資料來源: CDC MMWR*
